Short-term low carbohydrate/high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men

European Journal of Clinical Nutrition

Volumn 66, Issue 8, 2012, Pages 926-931

  Numao, S ^a,b   Kawano, H ^b   Endo, N ^b   Yamada, Y ^b   Konishi, M ^b   Takahashi, M ^b   Sakamoto, S ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

glucose dependent insulinotropic polypeptide; impaired glucose tolerance; incretin; postprandial hyperglycemia

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INCRETIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID DIET; LOW CARBOHYDRATE DIET; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PROTEIN ANALYSIS; PROTEIN HOMEOSTASIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MOTOR ACTIVITY; POSTPRANDIAL PERIOD;

EID: 84864856833     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.58     Document Type: Article

References (38)

1. DECODE group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
2. DECODE group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
3. Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394. (Pubitemid 38491233)
4. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359: 2072-2077. (Pubitemid 34680970)
5. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-494. (Pubitemid 37430502)
6. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 2009; 373: 1607-1614.
7. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T et a.l. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
8. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et a.l. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-2072. (Pubitemid 35192812)
9. Sakamoto T, Ogawa H, Kawano H, Hirai N, Miyamoto S, Takazoe K et a.l. Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost 2000; 83: 475-479. (Pubitemid 30148364)
10. Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F et a.l. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001; 73: 554-559. (Pubitemid 32176506)
11. Chokkalingam K, Jewell K, Norton L, Littlewood J, van Loon LJ, Mansell P et a.l. High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: an important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab 2007; 92: 284-292. (Pubitemid 46067545)
12. Cooper JA, Watras AC, Shriver T, Adams AK, Schoeller D.A. Influence of dietary fatty acid composition and exercise on changes in fat oxidation from a high-fat diet. J Appl Physiol 2010; 109: 1011-1018.
13. Hansen KC, Zhang Z, Gomez T, Adams AK, Schoeller D.A. Exercise increases the proportion of fat utilization during short-term consumption of a high-fat diet. Am J Clin Nutr 2007; 85: 109-116. (Pubitemid 46067623)
14. Harber MP, Schenk S, Barkan AL, Horowitz J.F. Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction. Am J Physiol Endocrinol Metab 2005; 289: E306-E312. (Pubitemid 41076633)
15. Peters SJ, Harris RA, Wu P, Pehleman TL, Heigenhauser GJ, Spriet L.L. Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. Am J Physiol Endocrinol Metab 2001; 281: E1151-E1158.
16. Schrauwen P, van Marken Lichtenbelt WD, Westerterp K.R. Changes in fat oxidation in response to a high-fat diet. Am J Clin Nutr 1997; 66: 276-282. (Pubitemid 27360325)
17. Brons C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS et a.l. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 2009; 587: 2387-2397.
18. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T et a.l. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50: 2579-2584. (Pubitemid 33642777)
19. Stettler R, Ith M, Acheson KJ, Decombaz J, Boesch C, Tappy L et a.l. Interaction between dietary lipids and physical inactivity on insulin sensitivity and on intramyocellular lipids in healthy men. Diabetes Care 2005; 28: 1404-1409. (Pubitemid 40756704)
20. Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson CH, O'Connor H et a.l. Effect of short-term starvation versus high-fat diet on intramyocellular triglyceride accumulation and insulin resistance in physically fit men. Exp Physiol 2006; 91: 693-703. (Pubitemid 43944640)
21. Drucker DJ, Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368: 1696-1705. (Pubitemid 46048557)
22. Hirmsworth H.P. The dietetic factor determining the glucose tolerance and sensitivity to insulin of healthy men. Clin Sci 1935; 2: 67-94.
23. Anderson JW, Herman R.H. Effects of carbohydrate restriction on glucose tolerance of normal men and reactive hypoglycemic patients. Am J Clin Nutr 1975; 28: 748-755.
24. Sparti A, Decombaz J. Effect of diet on glucose tolerance 36 h after glycogendepleting exercise. Eur J Clin Nutr 1992; 46: 377-385.
25. Pehleman TL, Peters SJ, Heigenhauser GJ, Spriet L.L. Enzymatic regulation of glucose disposal in human skeletal muscle after a high-fat, low-carbohydrate diet. J Appl Physiol 2005; 98: 100-107. (Pubitemid 40041235)
26. Ministry of Health Labour Welfare of Japan. Dietary reference intakes for Japanese, 2010. Daiichi Shuppan: Tokyo, Japan, 2010; in Japanese.
27. Friedewald WT, Levy RI, Fredrickson D.S. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
29. Mari A, Pacini G, Murphy E, Ludvik B, Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001; 24: 539-548. (Pubitemid 32198427)
30. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T et a.l. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301. (Pubitemid 30131733)
31. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Routledge Academic: UK, 1988.
32. Ferrannini E, Bjorkman O, Reichard Jr GA, DeFronzo R.A. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 1985; 34: 580-588. (Pubitemid 15044165)
33. Swinburn BA, Boyce VL, Bergman RN, Howard BV, Bogardus C. Deterioration in carbohydrate metabolism and lipoprotein changes induced by modern, high fat diet in Pima Indians and Caucasians. J Clin Endocrinol Metab 1991; 73: 156-165. (Pubitemid 21901115)
34. Oprescu AI, Bikopoulos G, Naassan A, Allister EM, Tang C, Park E et a.l. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 2007; 56: 2927-2937. (Pubitemid 350223627)
35. Chaikomin R, Doran S, Jones KL, Feinle-Bisset C, O'Donovan D, Rayner CK et a.l. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 2005; 289: E504-E507. (Pubitemid 41192706)
36. Clegg ME, McKenna P, McClean C, Davison GW, Trinick T, Duly E et a.l. Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men. Eur J Clin Nutr 2011; 65: 240-246.
37. Schrauwen P, Wagenmakers AJ, van Marken Lichtenbelt WD, Saris WH, Westerterp KR et a.l. Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes 2000; 49: 640-646. (Pubitemid 30183754)
38. Kiens B, Essen-Gustavsson B, Gad P, Lithell H. Lipoprotein lipase activity and intramuscular triglyceride stores after long-term high-fat and high-carbohydrate diets in physically trained men. Clin Physiol 1987; 7: 1-9. (Pubitemid 17004437)